Sight Diagnostics Alternatives & Competitors

12 companies similar to Sight Diagnostics — Morphology-Based Digital Blood Diagnostics

Truvian

blood testing anyone. anywhere.

108 Venture round $208.10M

San Diego, United States

Biotechnology Health Care +2

Compare

Haemokinesis

When every second counts.

Hallam, Australia

Biotechnology Health Care +1

Compare

EMPE Diagnostics

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resour...

27 Series A $42.94M

Solna, Sweden

Biotechnology Health Care +2

Fyodor Biotechnologies

Introducing a groundbreaking rapid test for malaria detection – an effortless, painless so...

Seed $1.47M

Biotechnology Health Care +1

Rival Readout

Competing with Sight Diagnostics? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Astek Diagnostics

One-hour antibiotic sensitivity testing

14 Non Equity Assistance $2.38M

Baltimore, United States

Health Care Medical Devices

HeartSciences (NASDAQ:HSCS)

Millions of ECGs are performed every week with technology that hasn't changed in 50 years....

20 Debt Financing $31.30M

Southlake, United States

AI Health Care +1

Avails Medical, Inc.

Avails Medical, Inc. - Affordable & Rapid Antibiotic Susceptibility Testing for clinical l...

51 Grant $11.61M

Menlo Park, United States

Health Care Medical Devices

hema.to GmbH

AI cytometry to advance precision immune medicine

16 Seed $7.20M

Germany

AI Health Care

PediaMetrix

Bringing technology based digital health solutions to pediatric care

12 Grant $4.34M

Rockville, United States

AI Health Care +2

Cellia Science

Point-of-Care Hematology

2 Debt Financing $300.00K

Fayetteville, United Stat...

Health Care Medical Devices

Scopio Labs

Full-Field Cell Morphology™ and AI-powered decision support, shaping the future of hematol...

143 Series D $115.07M

Israel

AI Analytics +3

Craif Inc.

Harnessing the power of urinary miRNA to detect cancer early

19 Non Equity Assistance $11.35M

Irvine, United States

AI Health Care +1

About Sight Diagnostics

Sight Diagnostics, with a last investment of $71.00M in a Series D round on 05 August 2020, is a groundbreaking player in the healthcare industry. The company's flagship product, Sight OLO, has redefined diagnostic testing by delivering a Complete Blood Count in a matter of minutes. This morphological-based digital blo...

Business keywords

Diagnostic Testing, Digital Health, AI In Healthcare, Blood Diagnostics, Morphology-Based Analysis, Rapid Testing, Precision Medicine, Healthcare Innovation, Healthcare Access, Malaria Detection, Global Health, Medical Imaging, Point-of-Care Testing

Frequently Asked Questions

Companies similar to Sight Diagnostics include Truvian, Haemokinesis, EMPE Diagnostics, Fyodor Biotechnologies, Astek Diagnostics. They work in Health Care and Medical Devices and share Sight Diagnostics's focus on healthcare innovation, point-of-care testing and digital health.

Bounce Watch lists 12 companies that share Sight Diagnostics's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Sight Diagnostics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Sight Diagnostics Profile Truvian Alternatives Haemokinesis Alternatives EMPE Diagnostics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Sight Diagnostics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.